Blythe Sather

Title: Blythe Sather: Innovator in HIV Research

Introduction

Blythe Sather is a prominent inventor based in Normandy Park, WA (US). She has made significant contributions to the field of HIV research through her innovative work in genetic modification of T-cells. Her dedication to advancing medical science is evident in her patent and collaborations with esteemed colleagues.

Latest Patents

Blythe Sather holds a patent for "CCR5 disruption of cells expressing anti-HIV chimeric antigen receptor (CAR) derived from broadly neutralizing antibodies." This patent relates to methods of genetically modifying T-cells that lack a co-receptor for HIV. The application outlines techniques for creating nucleic acids encoding a chimeric antigen receptor and genetically modified T-cells that can be used in treating, inhibiting, or ameliorating HIV in subjects.

Career Highlights

Blythe Sather is affiliated with Seattle Children's Hospital, where she continues her research and development in the field of immunology. Her work focuses on innovative approaches to combat HIV, showcasing her commitment to improving patient outcomes.

Collaborations

Blythe collaborates with notable colleagues, including Thor Wagner and Andrew M Scharenberg. These partnerships enhance her research efforts and contribute to the advancement of knowledge in the field.

Conclusion

Blythe Sather's contributions to HIV research through her patent and work at Seattle Children's Hospital highlight her role as an innovator in the medical field. Her dedication to developing new methods for treating HIV is commendable and reflects her commitment to improving health outcomes for patients.